Trials / Withdrawn
WithdrawnNCT04353310
Evaluating Effects of Curcumin in Moderate to Severe Asthmatics
Evaluating the Effects of Curcumin in Moderate to Severe Asthmatics
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Loma Linda University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this investigator-initiated study is to evaluate the effects of oral curcumin supplementation versus placebo in adult patients with moderate to severe asthma. Curcumin, a derivative of turmeric, has been shown in animal models to inhibit the secretion of pro-inflammatory cytokines and decrease airway constriction and hyperreactivity with only a few observational studies available in humans with discordant results.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Curcumin | Curcumin 1500mg PO BID |
| OTHER | Placebo | identical in appearance to curcumin |
Timeline
- Start date
- 2021-09-01
- Primary completion
- 2021-11-09
- Completion
- 2021-11-09
- First posted
- 2020-04-20
- Last updated
- 2021-11-17
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04353310. Inclusion in this directory is not an endorsement.